Peripheral blood lymphocyte subset counts in patients with dermatomyositis clinical correlations and changes following therapy

Medicine

Volumn 82, Issue 2, 2003, Pages 82-86

  Viguier, Manuelle ^a   Fouéré, Sébastien ^a   La Salmonière, Pauline De ^a   Rabian, Claire ^a   Lebbe, Céleste ^a   Dubertret, Louis ^a   Morel, Patrice ^a   Bachelez, Hervé ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISONE;

ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DERMATOMYOSITIS; FEMALE; FRANCE; HUMAN; INFECTION; INFECTION PREVENTION; INFECTION RISK; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; OPPORTUNISTIC INFECTION; PERIPHERAL LYMPHOCYTE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOPENIA; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 0037340554     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200303000-00002     Document Type: Article

References (22)

1. Bachelez H, Schremmer B, Cadranel J, Mouly F, Sarfati C, Agbalika F, Schlemmer B, Mayaud CM, Dubertret L. Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis. Arch Intern Med 157: 1501-3, 1997.
2. Behan WMH, Behan PO, Micklem HS, Durward WF. Lymphocytic subset abnormalities in polymyositis. Br Med J 287: 181-2, 1983.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (1 of 2 parts). N Engl J Med 292: 344-7, 1975.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (2 of 2 parts). N Engl J Med 292: 403-7, 1975.
5. Cambridge G, Faith A, Saunders C, Dubowitz V. A comparative study of in vitro proliferative responses to mitogens and immunoglobulin production in patients with inflammatory muscle disease. Clin Exp Rheum 7: 27-33, 1989.
6. Centers for Diseases Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.JAMA 267: 2294-6, 1992.
7. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487-98, 1991.
8. Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 162: 233-5, 1995.
9. Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, de Bandt M, Dellion S, Rossert J, Rostoker G, Piette JC, Schaeffer A. Pneumocystis carinii pneumonia in the course of connective tissue disease: Report of 34 cases. J Rheumatol 21: 246-51, 1994.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.
11. Iannone F, Cauli A, Yanni G, Kingsley GH, Isenberg DA, Corrigall V, Panayi GS. T-Lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br J Rheumatol 35: 839-45, 1996.
12. Iyer V, Lawton AR, Fenichel GM. T cell subsets in polymyositis. Ann Neurol 13: 452-3, 1983.
13. Jarrousse B, Guillevin L, Bindi P, Hachulla E, Leclerc P, Gilson B, Remy P, Rossert J, Jacquot C, Gilson B. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 11: 615-21, 1993.
14. Kadoya A, Okada J, Iikuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 23: 1186-8, 1996.
15. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, Lane HC, Urmacher C, Honig C, Longo DL, Parker MM, Natanson C, Parrillo JE, Fauci AS, Pizzo PA, Masur H. Pneumocystis carinii pneumonia: A comparison between patients with acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100: 663-71, 1984.
16. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, Davey R, Polls M, Metcalf J, Baseler M, Wesley R, Gill VJ, Fauci AS, Lane HC. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 111: 223-31, 1989.
17. Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH. Lymphocyte activation markers in idiopathic myositis: Changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 81: 373-9, 1990.
18. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, Leavitt RY. Pneumocystis carinii pneumonia: A major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 151: 795-9, 1995.
19. O'Gorman MR, Corrochano V, Roleck J, Donovan M, Pachman LM. Flow cytometric analyses of the lymphocyte subsets in peripheral blood of children with untreated active juvenile dermatomyositis. Clin Diagn Lab Immunol 2: 205-8, 1995.
20. Porges AJ, Beattie SL, Ritchlin C, Kimberly RP, Christian CL. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol 19: 1191-4, 1992.
21. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic and prognostic significance. Arthritis Rheum 21: 295-305, 1978.
22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7, 1982.